Hyperimmunoglobulinemia D with recurrent fever: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:
==Overview==
==Overview==
'''Hyperimmunoglobulinemia D with recurrent fever''' (commonly abbreviated as '''HIDS''') is a [[periodic fever syndrome]] originally described in [[1984]] by the [[internist]] Prof. Jos van der Meer, then at [[Leiden University]] [[Leiden University Medical Centre|Medical Centre]]. No more than 300 cases have been described worldwide.
'''Hyperimmunoglobulinemia D with recurrent fever''' (commonly abbreviated as '''HIDS''') is a [[periodic fever syndrome]] originally described in [[1984]] by the [[internist]] Prof. Jos van der Meer, then at [[Leiden University]] [[Leiden University Medical Centre|Medical Centre]]. No more than 300 cases have been described worldwide.
==Historical perspective==
* Hyperimmunoglobulinemia D with recurrent fever was first discovered by Prof. Jos van der Meer, a Dutch internist, in 1984 during the workup of 6 patients with recurrent fever.<ref name="Van Der MeerRadl1984">{{cite journal|last1=Van Der Meer|first1=JosW.M.|last2=Radl|first2=Jiri|last3=Meyer|first3=ChrisJ.L.M.|last4=Vossen|first4=JaakM.|last5=Van Nieuwkoop|first5=JannyA.|last6=Lobatto|first6=Sacha|last7=Van Furth|first7=Ralph|title=HYPERIMMUNOGLOBULINAEMIA D AND PERIODIC FEVER: A NEW SYNDROME|journal=The Lancet|volume=323|issue=8386|year=1984|pages=1087–1090|issn=01406736|doi=10.1016/S0140-6736(84)92505-4}}</ref>
*
==Pathophysiology==
==Pathophysiology==
Is it not known how mevalonate kinase mutations cause the febrile episodes, although it is presumed that other products of the cholesterol biosynthesis pathyway, the [[prenylation]] chains ([[geranylgeraniol]] and [[farnesol]]) might play a role.
Is it not known how mevalonate kinase mutations cause the febrile episodes, although it is presumed that other products of the cholesterol biosynthesis pathyway, the [[prenylation]] chains ([[geranylgeraniol]] and [[farnesol]]) might play a role.

Revision as of 20:45, 6 June 2019

WikiDoc Resources for Hyperimmunoglobulinemia D with recurrent fever

Articles

Most recent articles on Hyperimmunoglobulinemia D with recurrent fever

Most cited articles on Hyperimmunoglobulinemia D with recurrent fever

Review articles on Hyperimmunoglobulinemia D with recurrent fever

Articles on Hyperimmunoglobulinemia D with recurrent fever in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperimmunoglobulinemia D with recurrent fever

Images of Hyperimmunoglobulinemia D with recurrent fever

Photos of Hyperimmunoglobulinemia D with recurrent fever

Podcasts & MP3s on Hyperimmunoglobulinemia D with recurrent fever

Videos on Hyperimmunoglobulinemia D with recurrent fever

Evidence Based Medicine

Cochrane Collaboration on Hyperimmunoglobulinemia D with recurrent fever

Bandolier on Hyperimmunoglobulinemia D with recurrent fever

TRIP on Hyperimmunoglobulinemia D with recurrent fever

Clinical Trials

Ongoing Trials on Hyperimmunoglobulinemia D with recurrent fever at Clinical Trials.gov

Trial results on Hyperimmunoglobulinemia D with recurrent fever

Clinical Trials on Hyperimmunoglobulinemia D with recurrent fever at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperimmunoglobulinemia D with recurrent fever

NICE Guidance on Hyperimmunoglobulinemia D with recurrent fever

NHS PRODIGY Guidance

FDA on Hyperimmunoglobulinemia D with recurrent fever

CDC on Hyperimmunoglobulinemia D with recurrent fever

Books

Books on Hyperimmunoglobulinemia D with recurrent fever

News

Hyperimmunoglobulinemia D with recurrent fever in the news

Be alerted to news on Hyperimmunoglobulinemia D with recurrent fever

News trends on Hyperimmunoglobulinemia D with recurrent fever

Commentary

Blogs on Hyperimmunoglobulinemia D with recurrent fever

Definitions

Definitions of Hyperimmunoglobulinemia D with recurrent fever

Patient Resources / Community

Patient resources on Hyperimmunoglobulinemia D with recurrent fever

Discussion groups on Hyperimmunoglobulinemia D with recurrent fever

Patient Handouts on Hyperimmunoglobulinemia D with recurrent fever

Directions to Hospitals Treating Hyperimmunoglobulinemia D with recurrent fever

Risk calculators and risk factors for Hyperimmunoglobulinemia D with recurrent fever

Healthcare Provider Resources

Symptoms of Hyperimmunoglobulinemia D with recurrent fever

Causes & Risk Factors for Hyperimmunoglobulinemia D with recurrent fever

Diagnostic studies for Hyperimmunoglobulinemia D with recurrent fever

Treatment of Hyperimmunoglobulinemia D with recurrent fever

Continuing Medical Education (CME)

CME Programs on Hyperimmunoglobulinemia D with recurrent fever

International

Hyperimmunoglobulinemia D with recurrent fever en Espanol

Hyperimmunoglobulinemia D with recurrent fever en Francais

Business

Hyperimmunoglobulinemia D with recurrent fever in the Marketplace

Patents on Hyperimmunoglobulinemia D with recurrent fever

Experimental / Informatics

List of terms related to Hyperimmunoglobulinemia D with recurrent fever

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: HIDS

Overview

Hyperimmunoglobulinemia D with recurrent fever (commonly abbreviated as HIDS) is a periodic fever syndrome originally described in 1984 by the internist Prof. Jos van der Meer, then at Leiden University Medical Centre. No more than 300 cases have been described worldwide.

Historical perspective

  • Hyperimmunoglobulinemia D with recurrent fever was first discovered by Prof. Jos van der Meer, a Dutch internist, in 1984 during the workup of 6 patients with recurrent fever.[1]

Pathophysiology

Is it not known how mevalonate kinase mutations cause the febrile episodes, although it is presumed that other products of the cholesterol biosynthesis pathyway, the prenylation chains (geranylgeraniol and farnesol) might play a role.

Causes

Virtually all patients with the syndrome have mutations in the gene for mevalonate kinase, which is part of the HMG-CoA reductase pathway, an important cellular metabolic pathway (Drenth et al 1999, Houten et al 1999). Indeed, similar fever attacks (but normal IgD) have been described in patients with mevalonic aciduria - an inborn error of metabolism now seen as a severe form of HIDS.

Differentiating Hyperimmunoglobulinemia D with recurrent fever from other Diseases

The differential diagnosis includes fever of unknown origin, familial Mediterranean fever (FMF) and familial Hibernian fever (or TNFα reception associated periodic syndrome/TRAPS).

Epidemiology and Demographics

It has mainly been described in The Netherlands and France, although the international registry includes a number of cases from other countries.

Diagnosis

History and Symptoms

HIDS is one of a number of periodic fever syndromes. It is characterized by attacks of fever, arthralgia, skin lesions, and diarrhea.

Laboratory Findings

Laboratory features include an acute phase response (elevated CRP and ESR) and markedly elevated IgD (and often IgA), although cases with normal IgD have been described.

Medical Therapy

The recurring fevers are highly unpleasant for patients, but so far only the immunosuppressant drugs etanercept (Enbrel) and anakinra have been shown to be effective. Statin drugs might decrease the level of mevalonate and are presently being investigated.

References

  • Online Mendelian Inheritance in Man (OMIM) 260920
  • van der Meer JWM, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJLM, Lobatto S, van Furth R. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1984;I:1087-1090. PMID 6144826.
  • Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW, Delpech M. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 1999;22:178-81. PMID 10369262.
  • Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ, Frenkel J, Dorland L, de Barse MMJ, Huijbers WAR, Rijkers GT, Waterham HR, Wanders RJA, Poll-The BT. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nature Genet 1999;22:175-177. PMID 10369261.
  • Rigante D, Ansuini V, Bertoni B, Pugliese AL, Avallone L, Federico G, Stabile A. Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome. Rheumatol Int. 2006 Jul 27. PMID 16871408

Template:WH Template:WikiDoc Sources Template:Jb1

  1. Van Der Meer, JosW.M.; Radl, Jiri; Meyer, ChrisJ.L.M.; Vossen, JaakM.; Van Nieuwkoop, JannyA.; Lobatto, Sacha; Van Furth, Ralph (1984). "HYPERIMMUNOGLOBULINAEMIA D AND PERIODIC FEVER: A NEW SYNDROME". The Lancet. 323 (8386): 1087–1090. doi:10.1016/S0140-6736(84)92505-4. ISSN 0140-6736.